Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008833
Filing Date
2019-05-15
Accepted
2019-05-15 16:25:50
Documents
43
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_citiuspharma.htm 10-Q 277413
2 CERTIFICATION f10q0319ex31-1_citiuspharma.htm EX-31.1 10127
3 CERTIFICATION f10q0319ex31-2_citiuspharma.htm EX-31.2 10234
4 CERTIFICATION f10q0319ex32-1_citiuspharma.htm EX-32.1 4909
  Complete submission text file 0001213900-19-008833.txt   2209828

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ctxr-20190331.xml EX-101.INS 316553
6 XBRL SCHEMA FILE ctxr-20190331.xsd EX-101.SCH 36539
7 XBRL CALCULATION FILE ctxr-20190331_cal.xml EX-101.CAL 33359
8 XBRL DEFINITION FILE ctxr-20190331_def.xml EX-101.DEF 118700
9 XBRL LABEL FILE ctxr-20190331_lab.xml EX-101.LAB 246954
10 XBRL PRESENTATION FILE ctxr-20190331_pre.xml EX-101.PRE 182094
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 19828635
SIC: 2834 Pharmaceutical Preparations